ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001

In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named

June 15, 1990

Mass. Public Health Commissioner Koh Named To NCAB; Kovach To Direct Long Island Center.

October 27, 2000

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

ProPAC Calls For Adjustments In For Tobacco Advertising Ban

July 25, 1986